Stay updated on NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial page.

Latest updates to the NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNew user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) to help visitors navigate and interpret the study details. The page now shows that recruitment is closed and the intervention header formatting was adjusted, with an older revision notice removed.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5. This reflects a metadata version bump and does not modify study information.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page's revision stamp was updated to v3.5.4, replacing the previous v3.5.3 to reflect a new documentation version.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, indicating a maintenance release for the site rather than a change to the clinical trial information.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check100 days agoChange DetectedRevision updated to v3.5.0; prior revision v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial page.